GRI GRI Bio, Inc.

Fundamentals / CIK 0001824293 / USD

GRI Bio, Inc. reported $9.76M in total assets and a net loss of $7.81M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open GRI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$1.48M$738K$0-$12.20MFY 2020 Revenue: $100KFY 2020 Net Income: -$4.82M2020FY 2021 Revenue: $0FY 2021 Net Income: -$9.30M2021FY 2022 Net Income: -$3.22M2022FY 2023 Net Income: -$13.04M2023FY 2024 Net Income: -$8.21M2024FY 2025 Net Income: -$11.96M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- -- $0 $100K
Research & Development $6.82M $3.77M $3.23M $242K $5.19M $3.71M
Total Operating Expenses $11.98M $8.23M $11.39M $2.24M $9.26M $4.89M
Operating Income -$11.98M -$8.23M -$11.39M -$2.24M -$9.26M -$4.79M
EBITDA -$11.97M -$8.23M -$11.38M -$2.24M -- --
Income Tax Expense $3.0K $2.0K -- -- -- --
Net Income -$11.96M -$8.21M -$13.04M -$3.22M -$9.30M -$4.82M
Basic EPS -$121.80 -$1,545.55 -$6,693,487,957.60 -$160,854,335,804,675,328.00 -$274,919,998,366,268,864.00 -$207,158,026,937,963,200.00
Diluted EPS -$121.80 -$1,545.55 -$6,693,487,957.60 -$160,854,335,804,675,328.00 -$274,919,998,366,268,864.00 -$207,158,026,937,963,200.00
Basic Shares Outstanding 98.2K 6.5K 0 0 0 0
Diluted Shares Outstanding 98.2K 6.5K 0 0 0 0

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $212K $407K $361K $1.63M $1.77M $1.88M $1.64M $907K
Total Operating Expenses $1.51M $1.65M $2.00M $2.66M $3.37M $2.90M $3.05M $1.95M
Operating Income -$1.51M -$1.65M -$2.00M -$2.66M -$3.37M -$2.90M -$3.05M -$1.95M
EBITDA -$1.51M -$1.65M -$2.00M -$2.66M -$3.36M -$2.90M -$3.05M -$1.95M
Net Income -$1.51M -$1.64M -$2.00M -$2.66M -$3.36M -$2.89M -$3.05M -$1.95M
Basic EPS -$0.69 -$0.91 -$1.61 -- -$35.88 -$36.72 -$162.30 --
Diluted EPS -$0.69 -$0.91 -$1.61 -- -$35.88 -$36.72 -$162.30 --
Basic Shares Outstanding 2.2M 1.8M 1.2M -- 93.6K 78.8K 18.8K --
Diluted Shares Outstanding 2.2M 1.8M 1.2M -- 93.6K 78.8K 18.8K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $8.23M $5.03M $1.81M $9.0K $3.70M $109K
Short-Term Investments -- -- -- $0 $3.81M $0
Cash & Short-Term Investments $8.23M $5.03M $1.81M $9.0K $7.51M $109K
Total Current Assets $8.59M $5.62M $2.93M $312K $8.13M $674K
Property, Plant & Equipment, Net $3.0K $4.0K $8.0K $4.0K $0 $2.0K
Other Non-Current Assets -- -- -- $0 $206K $279K
Total Non-Current Assets $74K $124K $22K $71K $206K $281K
Total Assets $8.67M $5.74M $2.96M $383K $8.34M $955K
Accounts Payable $1.84M $897K $1.41M $1.29M $918K $1.23M
Other Current Liabilities -- -- -- $0 $97K $105K
Total Current Liabilities $2.64M $1.64M $2.70M $1.99M $2.44M $2.23M
Other Non-Current Liabilities -- -- -- $0 $72K $170K
Total Non-Current Liabilities $15K $71K $0 $14K $72K $184K
Total Liabilities $2.66M $1.71M $2.70M $2.01M $2.52M $2.41M
Total Debt (incl. Leases) $71K $119K $14K $71K $169K $275K
Retained Earnings -$51.70M -$39.74M -$31.53M -$18.50M -$21.90M -$12.60M
Accumulated Other Comp. Income -- -- -- $0 -$2.0K $0
Total Stockholders' Equity $6.01M $4.03M $259K -$1.62M -$4.85M -$1.45M
Total Equity $6.01M $4.03M $259K -$1.62M -$4.85M -$1.45M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $9.47M $10.95M $11.05M $8.23M $4.05M $5.12M $3.28M $5.03M
Cash & Short-Term Investments $9.47M $10.95M $11.05M $8.23M $4.05M $5.12M $3.28M $5.03M
Total Current Assets $9.73M $11.33M $11.28M $8.59M $4.70M $5.58M $3.93M $5.62M
Property, Plant & Equipment, Net $2.0K $2.0K $2.0K $3.0K $1.0K $2.0K $3.0K $4.0K
Total Non-Current Assets $32K $46K $60K $74K $85K $99K $112K $124K
Total Assets $9.76M $11.38M $11.34M $8.67M $4.78M $5.67M $4.04M $5.74M
Accounts Payable $354K $526K $303K $1.84M $1.32M $1.30M $1.36M $897K
Total Current Liabilities $953K $1.10M $794K $2.64M $2.76M $2.31M $2.78M $1.64M
Total Non-Current Liabilities $0 $0 $0 $15K $30K $44K $58K $71K
Total Liabilities $953K $1.10M $794K $2.66M $2.79M $2.35M $2.84M $1.71M
Total Debt (incl. Leases) $30K $44K $58K $71K $84K $96K $108K $119K
Retained Earnings -$56.84M -$55.34M -$53.69M -$51.70M -$49.04M -$45.68M -$42.79M -$39.74M
Total Stockholders' Equity $8.81M $10.28M $10.54M $6.01M $1.99M $3.32M $1.21M $4.03M
Total Equity $8.81M $10.28M $10.54M $6.01M $1.99M $3.32M $1.21M $4.03M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$11.96M -$8.21M -$13.04M -$3.22M -$9.30M -$4.82M
Depreciation & Amortization $4.0K $4.0K $4.0K $3.0K -- --
Stock-Based Compensation $793K $148K $388K $25K $626K $154K
Change in Payables $663K -$387K $2.16M $897K -$308K $980K
Operating Cash Flow -$10.19M -$8.61M -$8.99M -$1.08M -$8.31M -$3.71M
Capital Expenditure -$3.0K $0 -$8.0K -$3.0K $0 -$2.0K
Free Cash Flow -$10.19M -$8.61M -$9.00M -$1.09M -$8.31M -$3.71M
Purchases of Investments -- -- -- -$640K -$3.84M $0
Investing Cash Flow -$3.0K $0 -$8.0K -$3.0K -$3.84M -$2.0K
Common Stock Issued -- -- $12.25M $0 -- --
Financing Cash Flow $13.39M $11.83M $10.80M $1.01M $15.75M -$4.0K
Net Change in Cash $3.20M $3.22M $1.80M -$81K $3.59M -$3.71M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$1.51M -$1.64M -$2.00M -$2.66M -$3.36M -$2.89M -$3.05M -$1.95M
Depreciation & Amortization $0 $0 $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K
Stock-Based Compensation $32K $33K $31K $67K $465K $41K $220K $37K
Change in Payables -$172K $223K -$1.51M $272K $20K $40K $331K -$240K
Operating Cash Flow -$1.48M -$1.45M -$3.69M -$2.97M -$2.31M -$3.17M -$1.74M -$2.00M
Common Stock Issued -- -- $6.82M -- -- -- $0 --
Financing Cash Flow $0 $1.34M $6.50M $7.15M $1.25M $5.01M -$11K $2.28M
Net Change in Cash -$1.48M -$101K $2.82M $4.17M -$1.07M $1.84M -$1.75M $282K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -- -- -- -4788.0%
Net Profit Margin -- -- -- -- -- -4822.0%
Return on Equity (ROE) -199.0% -203.5% -5033.6% -- -- --
Return on Assets (ROA) -138.0% -143.0% -441.0% -839.9% -111.6% -504.9%
Current Ratio 3.25x 3.43x 1.09x 0.16x 3.32x 0.30x
Quick Ratio 3.11x 3.07x 0.67x 0.00x 3.07x 0.05x
Debt to Equity 0.01x 0.03x 0.05x -- -- --
Revenue Growth (YoY) -- -- -- -- -100.0% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -88.6% -94.0% -103.4% -199.0% -564.2% -301.3% -777.3% -203.6%
Return on Assets (ROA) -80.0% -84.9% -96.2% -138.0% -235.2% -176.4% -231.7% -143.0%
Current Ratio 10.21x 10.30x 14.21x 3.25x 1.70x 2.41x 1.41x 3.43x
Quick Ratio 9.94x 9.95x 13.91x 3.11x 1.47x 2.22x 1.18x 3.07x
Debt to Equity 0.00x 0.00x 0.01x 0.01x 0.04x 0.03x 0.09x 0.03x
Source: SEC EDGAR CompanyFacts (CIK 0001824293) · from March 31, 2020 Data through September 30, 2026 · synced Nov 21, 2026, 05:10 UTC · Open in terminal